Falcon's Beyond Global is navigating one of its sharpest weekly drawdowns since listing, with a stock collapse of 43% in a week colliding with an ORTEX short score near historic highs and a lending market that remains chronically tight.
The price action this week is the obvious starting point. FBYD closed at $10.72 on July 14, down 18% on the day alone and off 43% across the week. The one-month loss stands at 27%. For a stock with no disclosed market cap and a float thin enough to amplify every move, those are headline-grabbing numbers — but the more telling story is what was happening in the stock before the fall.
The dominant structural fact is that the largest holder has been a persistent, heavy seller. Infinite Acquisitions Partners — a 10% owner holding roughly 31% of shares — offloaded 3.95 million shares at $13.40 in April and another 1.39 million shares at $5.00 in early May, together totalling nearly $60 million in disclosed proceeds since March. That is not routine portfolio rebalancing. It is a controlling-level shareholder consistently reducing exposure across multiple price points, and it has left the register notably lighter. With net insider selling over the past 90 days approaching $75 million, the message from those closest to the business has been consistently one-directional.
The borrow market confirms the same caution from a different angle. Availability has tightened sharply to just 10.8% — meaning fewer than one share remains available to borrow for every nine already lent out. That is close to the worst availability readings of the past 30 days, when the pool briefly hit zero. Cost to borrow has eased from its June peak above 31% but remains elevated at 20.4%, still well above what most lenders consider a normal rate for an exchange-listed small-cap. Short interest itself is a more moderate 3.8% of free float — not alarming in isolation — but it has climbed 43% over the past month as the stock was rallying and selling pressure accumulated. The ORTEX short score sits at 80.5, near the top of the range it has held for the past two weeks, reflecting the combined weight of tight availability, elevated borrow cost, and rising short positioning.
The fundamental picture provides little obvious counterweight to the selling pressure. A previous ORTEX stock note flagged a 47% year-on-year revenue decline, deeply negative free cash flow, and near-zero scores on quality and growth pillars. Momentum had been the sole support for the score, which at the time sat near a six-month high — but that momentum has now violently reversed. The ORTEX factor rankings reinforce the cautionary read: the short score ranks in the first percentile of its universe, and the days-to-cover rank is zero, suggesting the borrow dynamics are as extreme as they get for a name of this size.
Earnings history adds one more wrinkle worth watching. After its March 30 print, the stock jumped 46% on the day and extended the move to nearly 27% over five days. After its May 14 release, the one-day gain was modest at 7% but the five-day follow-through reached 94%. Next earnings are pencilled in for August 13. Whether those post-announcement moves reflect genuine fundamental re-rating or the mechanics of a thinly traded float in a tight borrow environment is the question the setup poses — with availability already compressed and insider selling having already removed significant overhang, how the stock behaves into and around that print is the key thing to track between now and mid-August.
See the live data behind this article on ORTEX.
Open FBYD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
